title: Enhanced inhibition of tumor growth with depletion of CD25 regulatory cells and intratumoral immunization with tumor RNA-pulsed dendritic cells in a C57BL/6 pancreatic tumor model.
authors: Andrea
authors: A
authors: Linke
authors: Peter
authors: P
authors: Brossart
authors: Ingo G H
authors: IG
authors: Schmidt-Wolf
authors: Maria A
authors: MA
authors: Gonzalez-Carmona
authors: Carsten
authors: C
authors: Ziske
authors: Davorka
authors: D
authors: Messmer
authors: Volker
authors: V
authors: Schmitz
authors: Tilman
authors: T
authors: Sauerbruch
mesh_terms: D000818:Animals; D000906:Antibodies / Q000008:administration & dosage* / Q000276:immunology; D045744:Cell Line, Tumor; D003131:Combined Modality Therapy; D003713:Dendritic Cells / Q000166:cytology / Q000276:immunology* / Q000637:transplantation; D005260:Female; D016219:Immunotherapy, Adoptive / Q000379:methods; D053645:Interleukin-2 Receptor alpha Subunit / Q000276:immunology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010190:Pancreatic Neoplasms / Q000473:pathology / Q000628:therapy*; D012334:RNA, Neoplasm / Q000276:immunology*; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome; D047368:Tumor Burden / Q000187:drug effects / Q000276:immunology
chemical_list: D000906:Antibodies; D053645:Interleukin-2 Receptor alpha Subunit; D012334:RNA, Neoplasm